
Eventually up to five million people will have the opportunity to join Our Future Health
Harry Glorikian, Author & General Partner at Scientia Ventures, dives into the current and future applications of AI and other innovative health technologies, including for personalized medicine, drug development, public...

Report implies Europe must shift its focus to disease prevention